CNBX Pharmaceuticals Inc. (CNBX) › Operating Cash FlowCNBX Pharmaceuticals Inc. (CNBX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: $6.0K2016: -$120.1K2017: -$863.6K2018: -$1.97M2019: -$3.09M2020: -$2.77M2021: -$2.49M2022: -$1.68M2023: -$112.5K2024: -$244.3K2025: -$171.3K-$171.3K2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$171.3K+29.9%2024-$244.3K-117.1%2023-$112.5K+93.3%2022-$1.68M+32.6%2021-$2.49M+10.2%2020-$2.77M+10.3%2019-$3.09M-56.7%2018-$1.97M-128.7%2017-$863.6K-619.0%2016-$120.1K—2010$6.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share